Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Lupin Limited | Nagpur, India | Makes it and packages it | Problems found, fixed voluntarilyJul 11, 2023 · 4 inspections |
Recalls
- Jun 27, 2025 · Class II · Lupin Pharmaceuticals Inc.
Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during retention sample testing at expiry.
Lots: Lot # M300464, exp. date June, 2025 - Apr 10, 2025 · Class II · Lupin Pharmaceuticals Inc.
Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during 18-month long term stability study.
Lots: Lot #: M300442, Exp Date: 6/30/2025
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Clomipramine: every company that makes it
- Form
- capsule, oral
- Strength
- 75 mg
- Approval
- ANDA ANDA209294
- On the market since
- Feb 4, 2019
- Package NDCs
68180-494-0168180-494-0668180-494-0768180-494-09- Official label
- DailyMed (National Library of Medicine), updated Dec 16, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?